Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Investigating The Role of Hippocampal Dopamine in Early Life Adversity Effects on Fear Generalization

Award Number: R21MH140258
ORGANIZATION: NATIONAL INSTITUTE OF MENTAL HEALTH
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/15/2026
PERIOD OF PERFORMANCE END DATE: 07/14/2028

Group Awards By:

View Award Description

Investigating The Role of Hippocampal Dopamine in Early Life Adversity Effects on Fear Generalization - PROJECT SUMMARY: Fear generalization is an adaptive process by which a learned fear response to an aversive context is extended to a novel similar context. However, heightened fear generalization in the absence of persistent threat can lead to excessive fearfulness. Such overgeneralization of fear is observed in psychiatric disorders, such as generalized anxiety, PTSD, or depression. Early Life Adversity (ELA) is a major risk factor for these disorders, and generalization has indeed been proposed as a mechanism by which ELA increases risk for developing psychopathology. Understanding the neural mechanisms underlying fear generalization, and how they are affected by ELA, will thus be important to identify neural circuits regulating generalization during normal brain function, and how these circuits are affected in disease-relevant conditions. In this proposal, we will investigate how dopamine (DA) and norepinephrine (NE) release from locus coeruleus (LC) projections to the ventral dentate gyrus (vDG) of the hippocampus dynamically control and coordinate real-time neural responses during generalization, and how this regulation is disrupted by ELA. The vDG receives its main DA input from the LC. Our data show that ELA dampens DA signaling in the vDG, increases granule cell (GC) activity, and increases fear generalization. In Aim 1, we will now use in vivo imaging of DA biosensors and GC Ca2+ activity to study how ELA alters DA release in the vDG during fear generalization and how these temporal changes in DA release are associated with GC activity and freezing behavior. Because the predominant LC neurotransmitter is NE in addition to DA, we will also image NE release in combination with GC activity to compare how temporal dynamics of DA vs NE release in the vDG are associated with GC activity and freezing. In Aim 2, we will test whether LC-vDG projections increase fear generalization via NE, and whether they reduce fear generalization in ELA-exposed mice via DA. We will test these hypotheses using optogenetic stimulation of LC-vDG projections with simultaneous infusions of DA receptor antagonists or NE receptor antagonists into the vDG. In Aim 3, we will test the hypothesis that overlapping neural representations of an aversive and a novel context in the vDG are a neural correlate of generalization. We will use single cell in vivo Ca2+ imaging with head- mounted miniature microscopes to test whether GCs that encode an aversive context are reactivated more in a similar, but novel context in ELA-reared mice. We will then test whether DA release from LC projections disambiguates GC ensemble coding of fear and neutral contexts, and whether NE release from LC projections enhances overlap between GC ensembles for the two contexts. We will use machine learning techniques to predict how GC activity dynamics regulate freezing vs non-freezing behavior, and how they are affected by ELA and by DA vs NE. Overall, our study will use innovative neuroscience techniques to test a novel conceptual framework for how fear generalization is regulated at the neural circuit level, and how individual components of this circuit are modulated by ELA and by DA vs NE release from LC projections to the vDG.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $450,175 )
2026	2026	RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC.	1051 RIVERSIDE DR	NEW YORK	NY	10032	NEW YORK	USA	Mental Health Research Grants	000	1	7/13/2026	NEW	$450,175
														Subtotal = $450,175

Grand Total All Awards = $450,175

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Investigating The Role of Hippocampal Dopamine in Early Life Adversity Effects on Fear Generalization

Award Number: R21MH140258

ORGANIZATION: NATIONAL INSTITUTE OF MENTAL HEALTH

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/15/2026

PERIOD OF PERFORMANCE END DATE: 07/14/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer